Utilization and Outcomes Associated With Intravascular Ultrasound during Abdominal and Thoracic Endovascular Aortic Interventions in the United States in the Contemporary Era (2016–2023)

医学 血管内超声 危险系数 放射科 腔内修复术 腹主动脉瘤 主动脉瘤 动脉瘤 内科学 外科 心脏病学 置信区间
作者
Ramya Mosarla,Patrick Heindel,Mohamad A. Hussain,Marc L. Schermerhorn,Toshiki Kuno,Mario D’Oria,Siling Li,Eric A. Secemsky
出处
期刊:Circulation-cardiovascular Interventions [Ovid Technologies (Wolters Kluwer)]
标识
DOI:10.1161/circinterventions.124.014332
摘要

BACKGROUND: Intravascular ultrasound (IVUS) use in aortic endovascular interventions, including thoracic endovascular aneurysm repair (TEVAR) and endovascular aneurysm repair (EVAR), may have similar benefits to those seen in coronary and peripheral interventions, but limited utilization and outcome data exist. METHODS: Centers for Medicare and Medicaid Services claims data were used to identify patients undergoing TEVAR and EVAR from 2016 to 2023. Utilization trends were stratified by region, urbanicity, distressed communities index, community versus academic center, Medicare versus dual enrollment status, indication, urgency, and presence of dissection with malperfusion. Inverse probability weighting was used to assess the impact of IVUS on a composite outcome of repeat aortic intervention or death. Cox regression was used to estimate weighted hazard ratios. RESULTS: A total of 136 540 patients underwent TEVAR and EVAR, of which 9.8% (13 364) used IVUS. IVUS use increased slightly from 2016 to 2023, driven more by use in TEVAR compared with EVAR, and was higher in academic settings, with Medicare and Medicaid dual enrollment, in the West, with dissections, with malperfusion and for elective procedures. IVUS was associated with a lower risk of the primary outcome at 30-days (hazard ratio, 0.80 [95% CI, 0.73–0.89]; P <0.001) and 6-months (hazard ratio, 0.93 [95% CI, 0.87–0.99]; P =0.022) for all-comers. Subgroup analysis suggested lower risks of the primary outcome with IVUS use for aneurysm driven by the abdominal segment, malperfusion, thoracoabdominal dissection with malperfusion, thoracoabdominal repair, and chronic kidney disease. CONCLUSIONS: IVUS use has increased slightly in TEVAR and EVAR with heterogeneity in use. IVUS implementation during TEVAR and EVAR was associated with improved early and mid-term outcomes, particularly in certain subsets.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
cocolu举报susu求助涉嫌违规
刚刚
TARGET完成签到,获得积分10
刚刚
Neuro_dan完成签到,获得积分10
1秒前
1秒前
2秒前
JamesPei应助激昂的秀发采纳,获得10
3秒前
飞速get完成签到 ,获得积分10
3秒前
小羊肖恩发布了新的文献求助10
6秒前
lulu完成签到,获得积分10
7秒前
知性的绮兰完成签到,获得积分10
7秒前
研友_VZG7GZ应助ShuyueXue采纳,获得10
8秒前
干饭大大大大大王完成签到,获得积分10
8秒前
10秒前
cocolu应助biliobili采纳,获得10
12秒前
13秒前
田様应助一修采纳,获得10
13秒前
14秒前
14秒前
干净的人达完成签到 ,获得积分10
15秒前
TARGET关注了科研通微信公众号
15秒前
always发布了新的文献求助10
15秒前
xiaoyu完成签到,获得积分10
16秒前
16秒前
zzz发布了新的文献求助10
17秒前
17秒前
18秒前
秦琨发布了新的文献求助10
18秒前
JamesPei应助板凳采纳,获得10
19秒前
19秒前
小易发布了新的文献求助10
19秒前
ShuyueXue完成签到,获得积分10
20秒前
20秒前
不将就1345发布了新的文献求助10
20秒前
Qiao应助何哈哈采纳,获得10
20秒前
21秒前
gent发布了新的文献求助20
21秒前
xwwwww发布了新的文献求助10
21秒前
科目三应助zzz采纳,获得10
22秒前
CAIJING完成签到,获得积分10
22秒前
23秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
The Conscience of the Party: Hu Yaobang, China’s Communist Reformer 600
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3299776
求助须知:如何正确求助?哪些是违规求助? 2934644
关于积分的说明 8470036
捐赠科研通 2608208
什么是DOI,文献DOI怎么找? 1424075
科研通“疑难数据库(出版商)”最低求助积分说明 661827
邀请新用户注册赠送积分活动 645574